Literature DB >> 8755636

Defective cystathionine beta-synthase regulation by S-adenosylmethionine in a partially pyridoxine responsive homocystinuria patient.

L A Kluijtmans1, G H Boers, E M Stevens, W O Renier, J P Kraus, F J Trijbels, L P van den Heuvel, H J Blom.   

Abstract

We determined the molecular basis of cystathionine beta-synthase (CBS) deficiency in a partially pyridoxine-responsive homocystinuria patient. Direct sequencing of the entire CBS cDNA revealed the presence of a homozygous G1330A transition. This mutation causes an amino acid change from aspartic acid to asparagine (D444N) in the regulatory domain of the protein and abolishes a TaqI restriction site at DNA level. Despite the homozygous mutation, CBS activities in extracts of cultured fibroblasts of this patient were not in the homozygous but in the heterozygous range. Furthermore, we observed no stimulation of CBS activity by S-adenosylmethionine, contrary to a threefold stimulation in control fibroblast extract. The mutation was introduced in an E. coli expression system and CBS activities were measured after addition of different S-adenosylmethionine concentrations (0-200 microM). Again, we observed a defective stimulation of CBS activity by S-adenosylmethionine in the mutated construct, whereas the normal construct showed a threefold stimulation in activity. These data suggest that this D444N mutation interferes in S-adenosylmethionine regulation of CBS. Furthermore, it indicates the importance of S-adenosylmethionine regulation of the transsulfuration pathway in homocysteine homeostasis in humans.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8755636      PMCID: PMC507429          DOI: 10.1172/JCI118791

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  High frequency (71%) of cystathionine beta-synthase mutation G307S in Irish homocystinuria patients.

Authors:  P M Gallagher; P Ward; S Tan; E Naughten; J P Kraus; G C Sellar; D J McConnell; I Graham; A S Whitehead
Journal:  Hum Mutat       Date:  1995       Impact factor: 4.878

2.  Three different methods for the determination of total homocysteine in plasma.

Authors:  M T te Poele-Pothoff; M van den Berg; D G Franken; G H Boers; C Jakobs; I F de Kroon; T K Eskes; J M Trijbels; H J Blom
Journal:  Ann Clin Biochem       Date:  1995-03       Impact factor: 2.057

3.  A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase.

Authors:  P Frosst; H J Blom; R Milos; P Goyette; C A Sheppard; R G Matthews; G J Boers; M den Heijer; L A Kluijtmans; L P van den Heuvel
Journal:  Nat Genet       Date:  1995-05       Impact factor: 38.330

4.  The molecular basis of homocystinuria due to cystathionine beta-synthase deficiency in Italian families, and report of four novel mutations.

Authors:  G Sebastio; M P Sperandeo; M Panico; R de Franchis; J P Kraus; G Andria
Journal:  Am J Hum Genet       Date:  1995-06       Impact factor: 11.025

5.  Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease.

Authors:  L A Kluijtmans; L P van den Heuvel; G H Boers; P Frosst; E M Stevens; B A van Oost; M den Heijer; F J Trijbels; R Rozen; H J Blom
Journal:  Am J Hum Genet       Date:  1996-01       Impact factor: 11.025

6.  Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia.

Authors:  A M Engbersen; D G Franken; G H Boers; E M Stevens; F J Trijbels; H J Blom
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

7.  Identical genotypes in siblings with different homocystinuric phenotypes: identification of three mutations in cystathionine beta-synthase using an improved bacterial expression system.

Authors:  R de Franchis; V Kozich; R R McInnes; J P Kraus
Journal:  Hum Mol Genet       Date:  1994-07       Impact factor: 6.150

8.  Two novel missense mutations in the cystathionine beta-synthase gene in homocystinuric patients.

Authors:  L A Kluijtmans; H J Blom; G H Boers; B A van Oost; F J Trijbels; L P van den Heuvel
Journal:  Hum Genet       Date:  1995-08       Impact factor: 4.132

9.  Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida.

Authors:  N M van der Put; R P Steegers-Theunissen; P Frosst; F J Trijbels; T K Eskes; L P van den Heuvel; E C Mariman; M den Heyer; R Rozen; H J Blom
Journal:  Lancet       Date:  1995-10-21       Impact factor: 79.321

10.  Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations.

Authors:  P F Jacques; A G Bostom; R R Williams; R C Ellison; J H Eckfeldt; I H Rosenberg; J Selhub; R Rozen
Journal:  Circulation       Date:  1996-01-01       Impact factor: 29.690

View more
  29 in total

1.  Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding.

Authors:  P C Cheung; I P Salt; S P Davies; D G Hardie; D Carling
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

2.  CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations.

Authors:  John W Scott; Simon A Hawley; Kevin A Green; Miliea Anis; Greg Stewart; Gillian A Scullion; David G Norman; D Grahame Hardie
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

3.  S-Adenosylhomocysteine hydrolase deficiency: a second patient, the younger brother of the index patient, and outcomes during therapy.

Authors:  I Barić; M Cuk; K Fumić; O Vugrek; R H Allen; B Glenn; M Maradin; L Pazanin; I Pogribny; M Rados; V Sarnavka; A Schulze; S Stabler; C Wagner; S H Zeisel; S H Mudd
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

Review 4.  Disorders of homocysteine metabolism.

Authors:  B Fowler
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

5.  Surrogate genetics and metabolic profiling for characterization of human disease alleles.

Authors:  Jacob A Mayfield; Meara W Davies; Dago Dimster-Denk; Nick Pleskac; Sean McCarthy; Elizabeth A Boydston; Logan Fink; Xin Xin Lin; Ankur S Narain; Michael Meighan; Jasper Rine
Journal:  Genetics       Date:  2012-01-20       Impact factor: 4.562

Review 6.  One-Carbon Metabolism in Health and Disease.

Authors:  Gregory S Ducker; Joshua D Rabinowitz
Journal:  Cell Metab       Date:  2016-09-15       Impact factor: 27.287

7.  Structural basis of regulation and oligomerization of human cystathionine β-synthase, the central enzyme of transsulfuration.

Authors:  June Ereño-Orbea; Tomas Majtan; Iker Oyenarte; Jan P Kraus; Luis Alfonso Martínez-Cruz
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

8.  Cystathionine beta-synthase mutations: effect of mutation topology on folding and activity.

Authors:  Viktor Kozich; Jitka Sokolová; Veronika Klatovská; Jakub Krijt; Miroslav Janosík; Karel Jelínek; Jan P Kraus
Journal:  Hum Mutat       Date:  2010-07       Impact factor: 4.878

9.  Glycine N -methyltransferase deficiency: a new patient with a novel mutation.

Authors:  P Augoustides-Savvopoulou; Z Luka; S Karyda; S P Stabler; R H Allen; K Patsiaoura; C Wagner; S H Mudd
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

Review 10.  Bateman domains and adenosine derivatives form a binding contract.

Authors:  Bruce E Kemp
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.